Want to join the conversation?
Drug giant $ABT said it agreed to buy medical device maker $ALR for $56 per share, or $5.8Bil, to enter new geographies with an expanded portfolio. $ABT said it expects the deal to add to its ongoing earnings per share immediately upon close. Abbott's total diagnostics sales will exceed $7Bil after the deal, the company said.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.